21552 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF
#2MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
#3MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
#4HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#5INHIBITOR OF PROSTATE SPECIFIC MEMBRANE ANTIGEN AND PHARMACEUTICAL USE THEREOF
#6HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#7CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION
#8Probes for imaging huntingtin protein
#9NOVEL COMPOUNDS FOR DIAGNOSIS
#10Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#11HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#129H-pyrrolo-dipyridine derivatives
#13RADIOLABELED COMPOUNDS
#14Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#15MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
#16Small Molecules for Dual Function Positron Emission Tomography (PET) and Cell Suicide Switches
#17Heterocyclic compounds and imaging agents for imaging huntingtin protein
#189H-pyrrolo-dipyridine derivatives
#19Heterocyclic compounds for cancer imaging and treatment and methods for their use
#20Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#21Probes for imaging huntingtin protein
#22Small molecules for dual function positron emission tomography (PET) and cell suicide switches
#23Imaging of glycogen synthase kinase 3
#24Heterocyclic compounds for cancer imaging and treatment and methods for their use
#25Methylsulfonamide derivatives and uses related thereto
#269H-PYRROLO-DIPYRIDINE DERIVATIVES
#27Probes for imaging huntingtin protein
#28Alpha-synuclein ligands
#29USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS
#30Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
#31Nuclear medicine diagnostic imaging agent
#32Near-infrared fluorescent nerve contrast agents and methods of use thereof
#33Tau imaging probe
#34RADIOLABELED COMPOUNDS
#35Tau imaging probe
#36ONE POT SYNTHESIS OF 18F LABELEDTRIFLUOROMETHYLATED COMPOUNDS WITH DIFLUORO(IODO)METHANE
#37Halogenated benzoxazines and their use
#38Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
#39Highly Active Anti-Neoplastic and Anti-Proliferative Agents
#40Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
#411-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
#421,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
#43Tau imaging probe
#44Imaging Agents for Detecting Neurological Disorders
#45DIAGNOSTIC AGENT FOR INFECTIOUS DISEASES
#46Mitochondrial inhibitors to treat human disease
#47Novel Tricyclic Modulators of Cannabinoid Receptors
#48IMAGING LIGANDS
#49NOVEL SUBSTITUTED AZABENZOXAZOLES
#50DIAGNOSTIC PROBE FOR CONFORMATION DISEASE
#51Aβ-binding small molecules
#52PET PROBE HAVING AN ALKOXY GROUP SUBSTITUTED BY FLUORINE AND HYDROXY GROUP
#53Imaging agents for detecting neurological disorders
#54Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives
#55Benzoxazole derivatives
#56COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS
#57DIAGNOSTIC PROBE FOR CONFORMATION DISEASE
#58Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
#59Radioligands for the 5 -Ht1b Receptor
#60METHOD TO DETECT DOPAMINE RECEPTORS IN THE FUNCTIONAL D2HIGH STATE
#61PIPERAZINYL AND DIAZAPANYL BENZAMIDES AND BENZTHIOAMIDES
#62METHOD TO DETECT DOPAMINE RECEPTORS IN THE FUNCTIONAL D2HIGH STATE
#63Isotopically labelly indlinone derivatives and process for their preparation
#64Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
#65Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
#66Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
#672,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
#68Fused pyrrolecarboxamides: GABA brain receptor ligands